Financial Performance Expectations - The company expects a net profit loss between 46.10 million and 76.83 million yuan for the year 2024, compared to a profit of 6,357.00 million yuan in the previous year[3] - Total profit is projected to be a loss of 208.03 million to 346.72 million yuan, down from a profit of 7,210.04 million yuan last year[3] - The net profit after deducting non-recurring gains and losses is expected to be a loss of 804.35 million to 1,340.59 million yuan, compared to a profit of 3,339.70 million yuan in the previous year[3] Expense Increases - Increased R&D personnel and related costs have led to a significant rise in overall R&D expenses compared to last year[5] - The company has also seen an increase in management and sales personnel, contributing to higher overall expenses including salaries[6] Financial Reporting - The financial data presented is preliminary and has not been audited by the accounting firm, with detailed financial data to be disclosed in the 2024 annual report[7]
天益医疗(301097) - 2024 Q4 - 年度业绩预告